| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
|
Eur Heart J
|
2014
|
6.32
|
|
2
|
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
|
N Engl J Med
|
2008
|
6.00
|
|
3
|
Idarucizumab for Dabigatran Reversal.
|
N Engl J Med
|
2015
|
5.91
|
|
4
|
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
|
JAMA
|
2006
|
4.75
|
|
5
|
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis.
|
Arch Intern Med
|
2007
|
2.88
|
|
6
|
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
|
Circulation
|
2006
|
2.54
|
|
7
|
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
|
Circulation
|
2007
|
2.51
|
|
8
|
Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review.
|
Eur Heart J
|
2008
|
2.51
|
|
9
|
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.
|
Ann Intern Med
|
2011
|
2.28
|
|
10
|
Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design.
|
Am Heart J
|
2013
|
2.09
|
|
11
|
Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy.
|
J Rheumatol
|
2012
|
2.04
|
|
12
|
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
|
JAMA
|
2005
|
1.87
|
|
13
|
Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.
|
J Clin Oncol
|
2011
|
1.87
|
|
14
|
Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients.
|
Ann Intern Med
|
2003
|
1.83
|
|
15
|
Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease.
|
Eur Heart J
|
2013
|
1.76
|
|
16
|
Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads.
|
J Cardiovasc Electrophysiol
|
2004
|
1.72
|
|
17
|
Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism.
|
Arch Intern Med
|
2008
|
1.71
|
|
18
|
Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.
|
Am Heart J
|
2007
|
1.68
|
|
19
|
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.
|
Thromb Haemost
|
2008
|
1.64
|
|
20
|
Right ventricular function in patients with acute pulmonary embolism: analysis with electrocardiography-synchronized multi-detector row CT.
|
Radiology
|
2006
|
1.63
|
|
21
|
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension.
|
Eur Respir J
|
2012
|
1.55
|
|
22
|
Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism.
|
Radiology
|
2005
|
1.54
|
|
23
|
D-dimer testing in patients with suspected pulmonary embolism and impaired renal function.
|
Am J Med
|
2009
|
1.53
|
|
24
|
Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test.
|
Am J Med
|
2002
|
1.53
|
|
25
|
Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism.
|
Blood
|
2013
|
1.51
|
|
26
|
Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
|
J Clin Oncol
|
2008
|
1.49
|
|
27
|
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.
|
Diabetes Care
|
2004
|
1.46
|
|
28
|
[Suspicion of pulmonary embolism: added value of CT depends on patient characteristics and referring individual].
|
Ned Tijdschr Geneeskd
|
2012
|
1.45
|
|
29
|
Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review.
|
Am Heart J
|
2007
|
1.40
|
|
30
|
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
|
Clin Pharmacokinet
|
2008
|
1.39
|
|
31
|
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran.
|
Thromb Haemost
|
2015
|
1.36
|
|
32
|
Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis.
|
Am J Respir Crit Care Med
|
2008
|
1.24
|
|
33
|
Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.
|
Haematologica
|
2010
|
1.18
|
|
34
|
Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism.
|
Am J Respir Crit Care Med
|
2002
|
1.14
|
|
35
|
Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events.
|
Am J Respir Crit Care Med
|
2009
|
1.13
|
|
36
|
Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010.
|
Eur Heart J
|
2011
|
1.12
|
|
37
|
Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study.
|
J Clin Oncol
|
2005
|
1.12
|
|
38
|
The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study.
|
Chest
|
2007
|
1.12
|
|
39
|
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
|
Thromb Res
|
2007
|
1.08
|
|
40
|
VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies.
|
Thromb Haemost
|
2009
|
1.07
|
|
41
|
Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review.
|
Chest
|
2006
|
1.05
|
|
42
|
Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis.
|
Eur Respir J
|
2012
|
1.04
|
|
43
|
Quality of life in long-term survivors of acute pulmonary embolism.
|
Chest
|
2010
|
1.04
|
|
44
|
Association of aortic arch pulse wave velocity with left ventricular mass and lacunar brain infarcts in hypertensive patients: assessment with MR imaging.
|
Radiology
|
2009
|
1.02
|
|
45
|
Meta-analysis: serum creatinine changes following contrast enhanced CT imaging.
|
Eur J Radiol
|
2011
|
1.02
|
|
46
|
Computed tomography pulmonary angiography as a single imaging test to rule out pulmonary embolism.
|
Curr Opin Pulm Med
|
2011
|
1.01
|
|
47
|
Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound.
|
Br J Haematol
|
2003
|
0.98
|
|
48
|
Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism.
|
Thromb Haemost
|
2012
|
0.97
|
|
49
|
Diagnostic management of clinically suspected acute deep vein thrombosis.
|
Br J Haematol
|
2009
|
0.95
|
|
50
|
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.
|
Thromb Res
|
2013
|
0.95
|
|
51
|
Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.
|
Diabetes Care
|
2002
|
0.91
|
|
52
|
Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review.
|
Br J Haematol
|
2011
|
0.88
|
|
53
|
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
|
Thromb Haemost
|
2007
|
0.87
|
|
54
|
The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease.
|
Diabetes Care
|
2005
|
0.86
|
|
55
|
Bridging Anticoagulation in Patients with Atrial Fibrillation.
|
N Engl J Med
|
2016
|
0.84
|
|
56
|
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.
|
Chest
|
2013
|
0.84
|
|
57
|
The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
|
Eur J Intern Med
|
2007
|
0.84
|
|
58
|
Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice.
|
Haematologica
|
2006
|
0.84
|
|
59
|
Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells' simplified decision rule.
|
Thromb Haemost
|
2007
|
0.84
|
|
60
|
Measurement of right and left ventricular function by ECG-synchronized CT scanning in patients with acute pulmonary embolism: usefulness for predicting short-term outcome.
|
Chest
|
2011
|
0.84
|
|
61
|
Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism.
|
Am J Respir Crit Care Med
|
2013
|
0.83
|
|
62
|
Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism.
|
Intern Emerg Med
|
2011
|
0.83
|
|
63
|
The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
|
Haematologica
|
2004
|
0.83
|
|
64
|
Magnetic resonance imaging and computed tomography developments in imaging of venous thromboembolism.
|
J Magn Reson Imaging
|
2010
|
0.83
|
|
65
|
A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography.
|
Nephrol Dial Transplant
|
2014
|
0.83
|
|
66
|
Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism.
|
Eur Respir J
|
2012
|
0.83
|
|
67
|
Diagnosis of pulmonary embolism with spiral CT as a second procedure following scintigraphy.
|
Eur Radiol
|
2002
|
0.82
|
|
68
|
New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
|
Best Pract Res Clin Haematol
|
2013
|
0.81
|
|
69
|
Risk of arterial cardiovascular events in patients after pulmonary embolism.
|
Blood
|
2009
|
0.81
|
|
70
|
Excluding pulmonary embolism without imaging tests--can our diagnostic algorithm be optimized?
|
Thromb Haemost
|
2008
|
0.81
|
|
71
|
Diagnosing pulmonary embolism in pregnancy: Is there a role for D-dimer as a stand-alone test?
|
Crit Care Med
|
2006
|
0.81
|
|
72
|
Massive pulmonary embolism with cardiac arrest after an intracardiac electrophysiological study: a strong case for venous thromboprophylaxis.
|
Blood Coagul Fibrinolysis
|
2006
|
0.81
|
|
73
|
Diagnosis of pulmonary embolism: Advances and pitfalls.
|
Best Pract Res Clin Haematol
|
2012
|
0.81
|
|
74
|
Chronic pulmonary embolism and pulmonary hypertension.
|
Semin Respir Crit Care Med
|
2012
|
0.81
|
|
75
|
The physician's estimation 'alternative diagnosis is less likely than pulmonary embolism' in the Wells rule is dependent on the presence of other required items.
|
Thromb Haemost
|
2008
|
0.78
|
|
76
|
Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.
|
J Thromb Thrombolysis
|
2015
|
0.78
|
|
77
|
Performance of a diagnostic algorithm based on a prediction rule, D-dimer and CT-scan for pulmonary embolism in patients with previous venous thromboembolism. A systematic review and meta-analysis.
|
Thromb Haemost
|
2014
|
0.78
|
|
78
|
Imaging tests in the diagnosis of pulmonary embolism.
|
Semin Respir Crit Care Med
|
2012
|
0.77
|
|
79
|
The diagnostic management of recurrent deep vein thrombosis and pulmonary embolism.
|
Semin Respir Crit Care Med
|
2012
|
0.77
|
|
80
|
Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.
|
Thromb Haemost
|
2015
|
0.77
|
|
81
|
No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease.
|
Diabetes Care
|
2005
|
0.77
|
|
82
|
Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis.
|
Ann Intern Med
|
2016
|
0.77
|
|
83
|
No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT.
|
Eur Radiol
|
2015
|
0.77
|
|
84
|
Outcome of incidentally diagnosed pulmonary embolism in patients with malignancy.
|
Curr Opin Pulm Med
|
2012
|
0.77
|
|
85
|
Diagnosis and mortality prediction in pulmonary hypertension: the value of the electrocardiogram-derived ventricular gradient.
|
J Electrocardiol
|
2012
|
0.77
|
|
86
|
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
|
Expert Opin Ther Targets
|
2009
|
0.77
|
|
87
|
Repeated NT-proBNP testing and risk for adverse outcome after acute pulmonary embolism.
|
Thromb Haemost
|
2011
|
0.76
|
|
88
|
Dabigatran etexilate: advances in anticoagulation therapy.
|
Expert Rev Cardiovasc Ther
|
2010
|
0.76
|
|
89
|
Pulmonary flow profile and distensibility following acute pulmonary embolism.
|
J Cardiovasc Magn Reson
|
2011
|
0.76
|
|
90
|
The performance of two rapid quantitative D-dimer assays in 287 patients with clinically suspected pulmonary embolism.
|
Thromb Res
|
2002
|
0.76
|
|
91
|
Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge.
|
Thromb Haemost
|
2007
|
0.76
|
|
92
|
Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines.
|
Hypertension
|
2009
|
0.76
|
|
93
|
NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function.
|
Thromb Haemost
|
2012
|
0.76
|
|
94
|
Assessment of right ventricular function in acute pulmonary embolism using ECG-synchronized MDCT.
|
AJR Am J Roentgenol
|
2010
|
0.75
|
|
95
|
Low-molecular-weight heparins in the treatment of venous thromboembolism.
|
Curr Control Trials Cardiovasc Med
|
2000
|
0.75
|
|
96
|
Ultrasound-based diagnostic strategies for deep vein thrombosis.
|
JAMA
|
2009
|
0.75
|
|
97
|
Arterial indications for the low molecular weight heparins.
|
Curr Control Trials Cardiovasc Med
|
2001
|
0.75
|
|
98
|
[Perioperatief beleid wijzigen bij orale antistolling?].
|
Ned Tijdschr Geneeskd
|
2015
|
0.75
|
|
99
|
Reply to letter to the editor by Koza et al.
|
Am Heart J
|
2013
|
0.75
|
|
100
|
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
|
N Engl J Med
|
2003
|
0.75
|
|
101
|
The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism.
|
Diagn Interv Radiol
|
2015
|
0.75
|
|
102
|
Association of changes in D-dimer and other coagulation markers with changes in Marder score after treatment of acute venous thrombosis.
|
J Thromb Thrombolysis
|
2002
|
0.75
|
|
103
|
Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients.
|
Br J Haematol
|
2014
|
0.75
|
|
104
|
Utility of D-dimer testing in patients with clinically suspected pulmonary embolism and elevated C-reactive protein levels.
|
Thromb Haemost
|
2008
|
0.75
|
|
105
|
[Exclusion of deep-vein thrombosis and pulmonary embolism using clinical decision rules and D-dimer tests].
|
Ned Tijdschr Geneeskd
|
2010
|
0.75
|
|
106
|
Pulmonary embolism as a first clinical sign of occult malignancy: a prospective follow-up study.
|
Thromb Haemost
|
2006
|
0.75
|
|
107
|
Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
|
Thromb Haemost
|
2017
|
0.75
|
|
108
|
Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis.
|
Thromb Haemost
|
2006
|
0.75
|
|
109
|
Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism.
|
Thromb Haemost
|
2003
|
0.75
|
|
110
|
Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
|
Haematologica
|
2003
|
0.75
|
|
111
|
[Acute pulmonary embolism: beware of the wolf in sheep's clothing].
|
Ned Tijdschr Geneeskd
|
2012
|
0.75
|
|
112
|
Risk of atherothrombotic events in patients after proximal deep-vein thrombosis.
|
Blood Coagul Fibrinolysis
|
2016
|
0.75
|
|
113
|
Pharmacokinetics and Pharmacodynamics of Dabigatran 75 mg b.i.d. in Patients With Severe Chronic Kidney Disease.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
114
|
Is a V/Q scan based algorithm correctly used to diagnose acute pulmonary embolism? A daily practice survey.
|
Thromb Res
|
2011
|
0.75
|
|
115
|
Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism.
|
Thromb Haemost
|
2010
|
0.75
|
|
116
|
Update on techniques for the diagnosis of pulmonary embolism.
|
Expert Opin Med Diagn
|
2010
|
0.75
|
|
117
|
New anticoagulants.
|
Best Pract Res Clin Haematol
|
2013
|
0.75
|
|
118
|
Pharmacological strategies to reduce cardiovascular risk in type 2 diabetes mellitus: an update.
|
Drugs
|
2005
|
0.75
|
|
119
|
Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.
|
Thromb Haemost
|
2017
|
0.75
|